Wakefield Asset Management Lllp Coherus Bio Sciences, Inc. Transaction History

Wakefield Asset Management Lllp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$16.56 - $18.94 $470,900 - $538,577	-28,436 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$17.41 - $19.89 $3,830 - $4,375	220 Added 0.78%	28,436 $522,000
Q2 2020 Jul 28, 2020	SELL	$14.43 - $19.16 $85,916 - $114,078	-5,954 Reduced 17.42%	28,216 $504,000
Q1 2020 May 12, 2020	BUY	$11.67 - $22.53 $52,048 - $100,483	4,460 Added 15.01%	34,170 $554,000
Q4 2019 Jan 27, 2020	BUY	$16.33 - $21.37 $485,164 - $634,902	29,710 New	29,710 $535,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $97.9M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.